These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. [Anesthetic management for cesarean delivery in a pregnant patient with congenital antithrombin III deficiency and pulmonary thromboembolism]. Alonso A; Torre MD; Beisty JC Rev Esp Anestesiol Reanim; 2001; 48(6):285-7. PubMed ID: 11446944 [TBL] [Abstract][Full Text] [Related]
48. Use of antithrombin III concentrates to correct antithrombin III deficiency during vascular surgery. Jackson MR; Olsen SB; Gomez ER; Alving BM J Vasc Surg; 1995 Dec; 22(6):804-7. PubMed ID: 8523616 [TBL] [Abstract][Full Text] [Related]
50. Antithrombin III concentrate. Thromboprophylaxis during pregnancy in a patient with congenital antithrombin III deficiency. Tengborn L; Bengtsson T Acta Obstet Gynecol Scand; 1986; 65(4):375-6. PubMed ID: 3739652 [No Abstract] [Full Text] [Related]
52. Comparison between the effect of pentosan polysulphate heparin and antithrombin III injections in antithrombin III deficient patients. Fischer AM; Dautzenberg MD; Aurousseau MH; Béguin S; Goudemand J; Hemker HC Thromb Res; 1985 Jan; 37(2):295-307. PubMed ID: 2579452 [TBL] [Abstract][Full Text] [Related]
53. Rapid genetic diagnosis in neonatal pulmonary artery thrombosis caused by homozygous antithrombin Budapest 3. Brown SA; Mitchell M; Cutler JA; Moore G; Smith MP; Savidge GF Clin Appl Thromb Hemost; 2000 Jul; 6(3):181-3. PubMed ID: 10898281 [TBL] [Abstract][Full Text] [Related]
54. Subcutaneous heparin for thrombosis in pregnant women with hereditary antithrombin deficiency. Brandt P; Stenbjerg S Lancet; 1979 Jan; 1(8107):100-1. PubMed ID: 84100 [No Abstract] [Full Text] [Related]
55. Management of anti-thrombin III deficiency during pregnancy without administration of anti-thrombin III. Leclerc JR; Geerts W; Panju A; Nguyen P; Hirsh J Thromb Res; 1986 Feb; 41(4):567-73. PubMed ID: 3961735 [TBL] [Abstract][Full Text] [Related]
56. [Treatment of deep venous thrombosis in the presence of a congenital antithrombin III deficiency. Apropos of the use of purified concentrates]. Chamontin B; Guittard J; Laroche M; Boneu B; Salvador M Arch Mal Coeur Vaiss; 1984 Sep; 77(9):1064-7. PubMed ID: 6435583 [TBL] [Abstract][Full Text] [Related]
57. Antithrombotic drugs: part I. Gallus AS; Hirsh J Drugs; 1976; 12(1):41-68. PubMed ID: 789043 [TBL] [Abstract][Full Text] [Related]
58. [Changes in antithrombin III, prothrombin fragment 1 + 2 and thrombin-antithrombin III complex following implantation of a coronary Palmaz-Schatz stent]. Dittel M; Haushofer A; Spiel R; Halbmayer WM; Prachar H; Fischer M; Mlczoch J Z Kardiol; 1995 Jan; 84(1):22-9. PubMed ID: 7863710 [TBL] [Abstract][Full Text] [Related]
59. Anticoagulant therapy in living-related liver transplantation. Taniai N; Onda M; Tajiri T; Akimaru K; Yoshida H; Mamada Y; Yokomuro S; Mineta S; Yoshioka M; Hirakata A; Kawano Y; Mizuguchi Y Transplant Proc; 2002 Nov; 34(7):2788-90. PubMed ID: 12431612 [No Abstract] [Full Text] [Related]
60. Treatment of venous thrombosis in antithrombin III deficient patients with concentrates of antithrombin III. Winter JH; Fenech A; Mackie M; Bennett B; Douglas AS Clin Lab Haematol; 1982; 4(2):101-8. PubMed ID: 7116792 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]